Many studies reported that in 45% of NMO patients with AQP4-IgG, the disease process starts with an acute attack of ON15–17 and patients with isolated ON may not reach an EDSS score higher than 4, even if complete bilateral visual loss is present. The gene discussed is AQP4; the disease is neuromyelitis optica.